세계의 피내 주사기 시장 인사이트, 예측(-2029년)

The global Intradermal Injection Device market is projected to grow from US$ 109.10 million in 2023 to US$ 137.75 million by 2029, at a Compound Annual Growth Rate (CAGR) of 3.96% during the forecast period.

The US & Canada market for Intradermal Injection Device is estimated to increase from $ 19.79 million in 2023 to reach $ 24.09 million by 2029, at a CAGR of 3.33% during the forecast period of 2023 through 2029.

The China market for Intradermal Injection Device is estimated to increase from $ 15.64 million in 2023 to reach $ 23.51 million by 2029, at a CAGR of 7.03% during the forecast period of 2023 through 2029.

The Europe market for Intradermal Injection Device is estimated to increase from $ 22.82 million in 2023 to reach $ 28.16 million by 2029, at a CAGR of 3.56% during the forecast period of 2023 through 2029.

The global key manufacturers of Intradermal Injection Device include: Terumo, BD, NanoPass Technologies, Idevax, Debiotech, PharmaJet, and Debiotech, etc. In 2022, the global top five players had a share approximately 84.02% in terms of revenue.

Report Includes:

This report presents an overview of global market for Intradermal Injection Device, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.

This report researches the key producers of Intradermal Injection Device, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Intradermal Injection Device, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Intradermal Injection Device sales, revenue, market share and industry ranking of main manufacturers, data from 2018 to 2023. Identification of the major stakeholders in the global Intradermal Injection Device market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2018 to 2029. Evaluation and forecast the market size for Intradermal Injection Device sales, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including Terumo, BD, NanoPass Technologies, Idevax, Debiotech, PharmaJet, and Debiotech, etc.

By Company

• Terumo
• BD
• NanoPass Technologies
• Idevax
• Debiotech
• PharmaJet
• Debiotech
• Novosanis
• HIPRA
• Lightnix Inc

Segment by Type

• Disposable
• Reusable

Segment by Application

• Vaccine
• Medical Test
• Others

Segment by Region

• US & Canada
  • U.S.
  • Canada

• China

• Asia (excluding China)
  • Japan
  • South Korea
  • China Taiwan
  • Southeast Asia
  • India
  • Australia

• Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Russia

• Middle East, Africa, Latin America
  • Brazil
  • Mexico
  • Turkey
  • Israel
  • GCC Countries

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Sales (consumption), revenue of Intradermal Injection Device in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 3: Detailed analysis of Intradermal Injection Device manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.

Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.

Chapter 8: China by Type, and by Application, sales, and revenue for each segment.

Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.

Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.

Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Intradermal Injection Device sales, revenue, price, gross margin, and recent development, etc.

Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 14: The main points and conclusions of the report.

Table of Contents

1 STUDY COVERAGE

• 1.1 Intradermal Injection Device Product Introduction
• 1.2 Market by Type
  • 1.2.1 Global Intradermal Injection Device Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
  • 1.2.2 Disposable
  • 1.2.3 Reusable
• 1.3 Market by Application
  • 1.3.1 Global Intradermal Injection Device Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
  • 1.3.2 Vaccine
  • 1.3.3 Medical Test
  • 1.3.4 Others
• 1.4 Assumptions and Limitations
• 1.5 Study Objectives
• 1.6 Years Considered

2 EXECUTIVE SUMMARY

• 2.1 Global Intradermal Injection Device Revenue Estimates and Forecasts 2018-2029
• 2.2 Global Intradermal Injection Device Revenue by Region
  • 2.2.1 Global Intradermal Injection Device Revenue by Region: 2018 VS 2022 VS 2029
  • 2.2.2 Global Intradermal Injection Device Revenue by Region (2018-2023)
  • 2.2.3 Global Intradermal Injection Device Revenue by Region (2024-2029)
  • 2.2.4 Global Intradermal Injection Device Revenue Market Share by Region (2018-2029)
• 2.3 Global Intradermal Injection Device Sales Estimates and Forecasts 2018-2029
• 2.4 Global Intradermal Injection Device Sales by Region
  • 2.4.1 Global Intradermal Injection Device Sales by Region: 2018 VS 2022 VS 2029
  • 2.4.2 Global Intradermal Injection Device Sales by Region (2018-2023)
  • 2.4.3 Global Intradermal Injection Device Sales by Region (2024-2029)
  • 2.4.4 Global Intradermal Injection Device Sales Market Share by Region (2018-2029)
• 2.5 US & Canada
• 2.6 Europe
• 2.7 Asia-Pacific
• 2.8 Latin America
• 2.9 Middle East & Africa

3 COMPETITION BY MANUFACTURERS

• 3.1 Global Intradermal Injection Device Sales by Manufacturers
  • 3.1.1 Global Intradermal Injection Device Sales by Manufacturers (2018-2023)
  • 3.1.2 Global Intradermal Injection Device Sales Market Share by Manufacturers (2018-2023)
  • 3.1.3 Global Top 3 and Top 5 Largest Manufacturers of Intradermal Injection Device in 2022
• 3.2 Global Intradermal Injection Device Revenue by Manufacturers
  • 3.2.1 Global Intradermal Injection Device Revenue by Manufacturers (2018-2023)
  • 3.2.2 Global Intradermal Injection Device Revenue Market Share by Manufacturers (2018-2023)
  • 3.2.3 Global Top 3 and Top 5 Companies by Intradermal Injection Device Revenue in 2022
• 3.3 Global Key Players of Intradermal Injection Device, Industry Ranking, 2021 VS 2022
• 3.4 Global Intradermal Injection Device Sales Price by Manufacturers (2018-2023)
• 3.5 Analysis of Competitive Landscape
  • 3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
  • 3.5.2 Global Intradermal Injection Device Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
• 3.6 Global Key Manufacturers of Intradermal Injection Device, Manufacturing Base Distribution and Headquarters
• 3.7 Global Key Manufacturers of Intradermal Injection Device, Product Offered and Application
• 3.8 Global Key Manufacturers of Intradermal Injection Device, Date of Enter into This Industry
• 3.9 Mergers & Acquisitions, Expansion Plans

4 MARKET SIZE BY TYPE

• 4.1 Global Intradermal Injection Device Sales by Type
  • 4.1.1 Global Intradermal Injection Device Historical Sales by Type (2018-2023)
  • 4.1.2 Global Intradermal Injection Device Forecasted Sales by Type (2024-2029)
  • 4.1.3 Global Intradermal Injection Device Sales Market Share by Type (2018-2029)
• 4.2 Global Intradermal Injection Device Revenue by Type
  • 4.2.1 Global Intradermal Injection Device Historical Revenue by Type (2018-2023)
  • 4.2.2 Global Intradermal Injection Device Forecasted Revenue by Type (2024-2029)
  • 4.2.3 Global Intradermal Injection Device Revenue Market Share by Type (2018-2029)
• 4.3 Global Intradermal Injection Device Price by Type
  • 4.3.1 Global Intradermal Injection Device Price by Type (2018-2023)
  • 4.3.2 Global Intradermal Injection Device Price Forecast by Type (2024-2029)

5 MARKET SIZE BY APPLICATION

• 5.1 Global Intradermal Injection Device Sales by Application
  • 5.1.1 Global Intradermal Injection Device Historical Sales by Application (2018-2023)
  • 5.1.2 Global Intradermal Injection Device Forecasted Sales by Application (2024-2029)
  • 5.1.3 Global Intradermal Injection Device Sales Market Share by Application (2018-2029)
• 5.2 Global Intradermal Injection Device Revenue by Application
  • 5.2.1 Global Intradermal Injection Device Historical Revenue by Application (2018-2023)
  • 5.2.2 Global Intradermal Injection Device Forecasted Revenue by Application (2024-2029)
  • 5.2.3 Global Intradermal Injection Device Revenue Market Share by Application (2018-2029)
• 5.3 Global Intradermal Injection Device Price by Application
  • 5.3.1 Global Intradermal Injection Device Price by Application (2018-2023)
  • 5.3.2 Global Intradermal Injection Device Price Forecast by Application (2024-2029)

6 US & CANADA

• 6.1 US & Canada Intradermal Injection Device Market Size by Type
  • 6.1.1 US & Canada Intradermal Injection Device Sales by Type (2018-2029)
  • 6.1.2 US & Canada Intradermal Injection Device Revenue by Type (2018-2029)
• 6.2 US & Canada Intradermal Injection Device Market Size by Application
  • 6.2.1 US & Canada Intradermal Injection Device Sales by Application (2018-2029)
  • 6.2.2 US & Canada Intradermal Injection Device Revenue by Application (2018-2029)
• 6.3 US & Canada Intradermal Injection Device Market Size by Country
  • 6.3.1 US & Canada Intradermal Injection Device Revenue by Country: 2018 VS 2022 VS 2029
  • 6.3.2 US & Canada Intradermal Injection Device Revenue by Country (2018-2029)
  • 6.3.3 US & Canada Intradermal Injection Device Sales by Country (2018-2029)
  • 6.3.4 US
  • 6.3.5 Canada

7 EUROPE

• 7.1 Europe Intradermal Injection Device Market Size by Type
  • 7.1.1 Europe Intradermal Injection Device Sales by Type (2018-2029)
  • 7.1.2 Europe Intradermal Injection Device Revenue by Type (2018-2029)
• 7.2 Europe Intradermal Injection Device Market Size by Application
  • 7.2.1 Europe Intradermal Injection Device Sales by Application (2018-2029)
  • 7.2.2 Europe Intradermal Injection Device Revenue by Application (2018-2029)
• 7.3 Europe Intradermal Injection Device Market Size by Country
  • 7.3.1 Europe Intradermal Injection Device Revenue by Country: 2018 VS 2022 VS 2029
  • 7.3.2 Europe Intradermal Injection Device Revenue by Country (2018-2029)
  • 7.3.3 Europe Intradermal Injection Device Sales by Country (2018-2029)
  • 7.3.4 Germany
  • 7.3.5 France
  • 7.3.6 U.K.
  • 7.3.7 Italy
  • 7.3.8 Russia

8 ASIA-PACIFIC

• 8.1 Asia-Pacific Intradermal Injection Device Market Size by Type
  • 8.1.1 Asia-Pacific Intradermal Injection Device Sales by Type (2018-2029)
  • 8.1.2 Asia-Pacific Intradermal Injection Device Revenue by Type (2018-2029)
• 8.2 Asia-Pacific Intradermal Injection Device Market Size by Application
  • 8.2.1 Asia-Pacific Intradermal Injection Device Sales by Application (2018-2029)
  • 8.2.2 Asia-Pacific Intradermal Injection Device Revenue by Application (2018-2029)
• 8.3 Asia-Pacific Intradermal Injection Device Market Size by Region
  • 8.3.1 Asia-Pacific Intradermal Injection Device Revenue by Region: 2018 VS 2022 VS 2029
  • 8.3.2 Asia-Pacific Intradermal Injection Device Revenue by Region (2018-2029)
  • 8.3.3 Asia-Pacific Intradermal Injection Device Sales by Region (2018-2029)
  • 8.3.4 China
  • 8.3.5 Japan
  • 8.3.6 South Korea
  • 8.3.7 India
  • 8.3.8 Southeast Asia-Pacific

9 LATIN AMERICA

• 9.1 Latin America Intradermal Injection Device Market Size by Type
  • 9.1.1 Latin America Intradermal Injection Device Sales by Type (2018-2029)
  • 9.1.2 Latin America Intradermal Injection Device Revenue by Type (2018-2029)
• 9.2 Latin America Intradermal Injection Device Market Size by Application
  • 9.2.1 Latin America Intradermal Injection Device Sales by Application (2018-2029)
  • 9.2.2 Latin America Intradermal Injection Device Revenue by Application (2018-2029)
• 9.3 Latin America Intradermal Injection Device Market Size by Region
  • 9.3.1 Latin America Intradermal Injection Device Revenue by Region: 2018 VS 2022 VS 2029
  • 9.3.2 Latin America Intradermal Injection Device Revenue by Country (2018-2029)
  • 9.3.3 Latin America Intradermal Injection Device Sales by Country (2018-2029)
  • 9.3.4 Mexico
  • 9.3.5 Brazil

10 MIDDLE EAST AND AFRICA

• 10.1 Middle East and Africa Intradermal Injection Device Market Size by Type
  • 10.1.1 Middle East and Africa Intradermal Injection Device Sales by Type (2018-2029)
  • 10.1.2 Middle East and Africa Intradermal Injection Device Revenue by Type (2018-2029)
• 10.2 Middle East and Africa Intradermal Injection Device Market Size by Application
  • 10.2.1 Middle East and Africa Intradermal Injection Device Sales by Application (2018-2029)
  • 10.2.2 Middle East and Africa Intradermal Injection Device Revenue by Application (2018-2029)
• 10.3 Middle East and Africa Intradermal Injection Device Market Size by Region
  • 10.3.1 Middle East and Africa Intradermal Injection Device Revenue by Region: 2018 VS 2022 VS 2029
  • 10.3.2 Middle East and Africa Intradermal Injection Device Revenue by Country (2018-2029)
  • 10.3.3 Middle East and Africa Intradermal Injection Device Sales by Country (2018-2029)
  • 10.3.4 Middle East
  • 10.3.5 Africa

11 CORPORATE PROFILE

• 11.1 BD
  • 11.1.1 BD Company Information
  • 11.1.2 BD Overview
  • 11.1.3 BD Intradermal Injection Device Sales, Price, Revenue and Gross Margin (2018-2023)
  • 11.1.4 BD Intradermal Injection Device Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.1.5 BD Recent Developments
• 11.2 Terumo
  • 11.2.1 Terumo Company Information
  • 11.2.2 Terumo Overview
  • 11.2.3 Terumo Intradermal Injection Device Sales, Price, Revenue and Gross Margin (2018-2023)
  • 11.2.4 Terumo Intradermal Injection Device Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.2.5 Terumo Recent Developments
• 11.3 HIPRA
  • 11.3.1 HIPRA Company Information
  • 11.3.2 HIPRA Overview
  • 11.3.3 HIPRA Intradermal Injection Device Sales, Price, Revenue and Gross Margin (2018-2023)
  • 11.3.4 HIPRA Intradermal Injection Device Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.3.5 HIPRA Recent Developments
• 11.4 NanoPass Technologies
  • 11.4.1 NanoPass Technologies Company Information
  • 11.4.2 NanoPass Technologies Overview
  • 11.4.3 NanoPass Technologies Intradermal Injection Device Sales, Price, Revenue and Gross Margin (2018-2023)
  • 11.4.4 NanoPass Technologies Intradermal Injection Device Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.4.5 NanoPass Technologies Recent Developments
• 11.5 Novosanis (Idevax)
  • 11.5.1 Novosanis (Idevax) Company Information
  • 11.5.2 Novosanis (Idevax) Overview
  • 11.5.3 Novosanis (Idevax) Intradermal Injection Device Sales, Price, Revenue and Gross Margin (2018-2023)
  • 11.5.4 Novosanis (Idevax) Intradermal Injection Device Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.5.5 Novosanis (Idevax) Recent Developments
• 11.6 Idevax
  • 11.6.1 Idevax Company Information
  • 11.6.2 Idevax Overview
  • 11.6.3 Idevax Recent Developments
• 11.7 PharmaJet
  • 11.7.1 PharmaJet Company Information
  • 11.7.2 PharmaJet Overview
  • 11.7.3 PharmaJet Intradermal Injection Device Sales, Price, Revenue and Gross Margin (2018-2023)
  • 11.7.4 PharmaJet Intradermal Injection Device Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.7.5 PharmaJet Recent Developments
• 11.8 Debiotech
  • 11.8.1 Debiotech Company Information
  • 11.8.2 Debiotech Overview
  • 11.8.3 Debiotech Intradermal Injection Device Sales, Price, Revenue and Gross Margin (2018-2023)
  • 11.8.4 Debiotech Intradermal Injection Device Product Model Numbers, Pictures, Descriptions and Specifications
• 11.9 Lightnix Inc
  • 11.9.1 Lightnix Inc Company Information
  • 11.9.2 Lightnix Inc Overview
  • 11.9.3 Lightnix Inc Intradermal Injection Device Product Model Numbers, Pictures, Descriptions and Specifications

12 INDUSTRY CHAIN AND SALES CHANNELS ANALYSIS

• 12.1 Intradermal Injection Device Industry Chain Analysis
• 12.2 Intradermal Injection Device Key Raw Materials
  • 12.2.1 Key Raw Materials
  • 12.2.2 Raw Materials Key Suppliers
• 12.3 Intradermal Injection Device Production Mode & Process
• 12.4 Intradermal Injection Device Sales and Marketing
  • 12.4.1 Intradermal Injection Device Distributors
• 12.5 Intradermal Injection Device Customers

13 INTRADERMAL INJECTION DEVICE MARKET DYNAMICS

• 13.1.1 Intradermal Injection Device Industry Trends
• 13.1.2 Intradermal Injection Device Market Drivers
• 13.1.3 Intradermal Injection Device Market Challenges
• 13.1.4 Intradermal Injection Device Market Restraints

14 KEY FINDINGS IN THE GLOBAL INTRADERMAL INJECTION DEVICE STUDY

15 APPENDIX

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Author Details
• 15.3 Disclaimer